PMID- 8806963 OWN - NLM STAT- MEDLINE DCOM- 19961204 LR - 20190905 IS - 0193-1091 (Print) IS - 0193-1091 (Linking) VI - 18 IP - 3 DP - 1996 Jun TI - Immunohistochemical study of CD34-positive dendritic cells of human dermis. PG - 283-8 AB - The human dermis contains a heterogeneous network of cells with a dendritic morphology, including factor XIIIa+ dermal dendrocytes and CD34+ dendritic cells located around epidermal adnexae. Whereas dermal dendrocytes have been immunohistochemically studied, CD34+ dermal cells have not yet been well characterized. We studied by simple and double immunolabeling techniques on tissue sections of normal human skin the phenotype of these cells and found them to express vimentin and Te7 but none of the remaining markers sought (factor XIIIa, von Willebrand factor, CD1a, CD3, CD4, CD8, CD14, CD25, CD36, CD45, CD54, CD56, LFA-1, EGF-R, S-100 protein, Mac 387, and muscle-specific actin). Rare CD34+ cells of the interstitial dermis expressed human leukocyte antigen (HLA)-DR antigens, but this was not the case for periadnexal CD34+ cells. These results show that CD34+ dendritic cells of human dermis are mesenchymal cells bearing a unique immunophenotype different from that of (myo)fibroblasts, monocytes-macrophages, Langerhans cells, and factor XIIIa+ dermal dendrocytes. Whereas the involvement of CD34+ cells in some cutaneous tumors is well known, their physiologic role in normal skin remains to be established. On the basis of our results, we speculate that these cells could represent uncommitted mesenchymal cells, unique by virtue of CD34 antigen expression. FAU - Narvaez, D AU - Narvaez D AD - Department of Dermatology, Ed. Herriot Hospital, Lyon, France. FAU - Kanitakis, J AU - Kanitakis J FAU - Faure, M AU - Faure M FAU - Claudy, A AU - Claudy A LA - eng PT - Journal Article PL - United States TA - Am J Dermatopathol JT - The American Journal of dermatopathology JID - 7911005 RN - 0 (Actins) RN - 0 (Antigens, CD1) RN - 0 (Antigens, CD34) RN - 0 (CD3 Complex) RN - 0 (CD36 Antigens) RN - 0 (CD4 Antigens) RN - 0 (CD56 Antigen) RN - 0 (CD8 Antigens) RN - 0 (HLA-DR Antigens) RN - 0 (Lipopolysaccharide Receptors) RN - 0 (Lymphocyte Function-Associated Antigen-1) RN - 0 (Receptors, Interleukin-2) RN - 0 (S100 Proteins) RN - 0 (Vimentin) RN - 0 (von Willebrand Factor) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - EC 2.3.2.13 (Transglutaminases) RN - EC 2.7.10.1 (ErbB Receptors) RN - EC 3.1.3.48 (Leukocyte Common Antigens) SB - IM CIN - Am J Dermatopathol. 1998 Oct;20(5):533-6. PMID: 9790122 MH - Actins/analysis MH - Antigens, CD1/analysis MH - Antigens, CD34/*analysis MH - CD3 Complex/analysis MH - CD36 Antigens/analysis MH - CD4 Antigens/analysis MH - CD56 Antigen/analysis MH - CD8 Antigens/analysis MH - Dendritic Cells/*cytology/immunology MH - ErbB Receptors/analysis MH - Fibroblasts/cytology MH - HLA-DR Antigens/analysis MH - Humans MH - Immunohistochemistry MH - Immunophenotyping MH - Intercellular Adhesion Molecule-1/analysis MH - Leukocyte Common Antigens/analysis MH - Lipopolysaccharide Receptors/analysis MH - Lymphocyte Function-Associated Antigen-1/analysis MH - Macrophages/cytology MH - Monocytes/cytology MH - Receptors, Interleukin-2/analysis MH - S100 Proteins/analysis MH - Skin/*cytology/immunology MH - Transglutaminases/analysis MH - Vimentin/analysis MH - von Willebrand Factor/analysis EDAT- 1996/06/01 00:00 MHDA- 1996/06/01 00:01 CRDT- 1996/06/01 00:00 PHST- 1996/06/01 00:00 [pubmed] PHST- 1996/06/01 00:01 [medline] PHST- 1996/06/01 00:00 [entrez] AID - 10.1097/00000372-199606000-00008 [doi] PST - ppublish SO - Am J Dermatopathol. 1996 Jun;18(3):283-8. doi: 10.1097/00000372-199606000-00008.